Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Cervera

Showing results (41-50 of 412) with videos related to

Pageof 42
Sort By:
Lupus|February 18, 2006
Epidemiology of systemic lupus erythematosus at the change of the millennium: lessons from the Euro-Lupus and the LUMINA projectsRicard Cervera, Munther A Khamashta
The Israel Medical Association Journal : IMAJ|May 5, 2006
Primary pulmonary arterial hypertension and the systemic autoimmune diseasesRicard Cervera, Ronald A Asherson
Clinical Reviews in Allergy & Immunology|June 10, 2003
Unusual manifestations of the antiphospholipid syndromeRonald A Asherson, Ricard Cervera
Autoimmunity Reviews|July 10, 2003
The antiphospholipid syndrome: multiple faces beyond the classical presentationRonald A Asherson, Ricard Cervera
The Israel Medical Association Journal : IMAJ|July 31, 2015
New Autoantibodies in Inflammatory Myopathies: Diagnostic Value and Relationship with Clinical PhenotypesAlbert Selva-O'Callaghan, Ricard Cervera
Expert Review of Clinical Immunology|May 19, 2010
Catastrophic antiphospholipid syndrome: therapeutic developmentsRicard Cervera, Ronald A Asherson
Current Rheumatology Reports|September 12, 2003
Catastrophic antiphospholipid syndromeRonald A Asherson, Ricard Cervera
British Journal of Hospital Medicine (London, England : 2005)|October 7, 2008
Catastrophic antiphospholipid (Asherson's) syndromeRicard Cervera, Ronald A Asherson
Immunobiology|March 18, 2003
Clinical and epidemiological aspects in the antiphospholipid syndromeRicard Cervera, Ronald A Asherson
Autoimmunity Reviews|January 15, 2008
Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?Ronald A Asherson, Ricard Cervera
Pageof 42

Showing results (41-50 of 412) with videos related to

Sort By:
Pageof 42
Lupus|February 18, 2006
Epidemiology of systemic lupus erythematosus at the change of the millennium: lessons from the Euro-Lupus and the LUMINA projectsRicard Cervera, Munther A Khamashta
The Israel Medical Association Journal : IMAJ|May 5, 2006
Primary pulmonary arterial hypertension and the systemic autoimmune diseasesRicard Cervera, Ronald A Asherson
Clinical Reviews in Allergy & Immunology|June 10, 2003
Unusual manifestations of the antiphospholipid syndromeRonald A Asherson, Ricard Cervera
Autoimmunity Reviews|July 10, 2003
The antiphospholipid syndrome: multiple faces beyond the classical presentationRonald A Asherson, Ricard Cervera
The Israel Medical Association Journal : IMAJ|July 31, 2015
New Autoantibodies in Inflammatory Myopathies: Diagnostic Value and Relationship with Clinical PhenotypesAlbert Selva-O'Callaghan, Ricard Cervera
Expert Review of Clinical Immunology|May 19, 2010
Catastrophic antiphospholipid syndrome: therapeutic developmentsRicard Cervera, Ronald A Asherson
Current Rheumatology Reports|September 12, 2003
Catastrophic antiphospholipid syndromeRonald A Asherson, Ricard Cervera
British Journal of Hospital Medicine (London, England : 2005)|October 7, 2008
Catastrophic antiphospholipid (Asherson's) syndromeRicard Cervera, Ronald A Asherson
Immunobiology|March 18, 2003
Clinical and epidemiological aspects in the antiphospholipid syndromeRicard Cervera, Ronald A Asherson
Autoimmunity Reviews|January 15, 2008
Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?Ronald A Asherson, Ricard Cervera
Pageof 42